Results 31 to 40 of about 60,986 (304)

Natural Killer Cell-Mediated Cellular Therapy of Hematological Malignancies

open access: yesClinical Hematology International, 2019
Our understanding on the mechanisms of graft versus tumor/leukemia (GvT/GvL) and graft versus host (GvH) effects has tremendously evolved within the past decades.
Ugur Sahin, Meral Beksac
doaj   +1 more source

Beyond the antigen receptor: editing the genome of T-cells for cancer adoptive cellular therapies

open access: yesFrontiers in Immunology, 2013
Recent early-stage clinical trials evaluating the adoptive transfer of patient CD8+ T-cells re-directed with antigen receptors recognising tumours have shown very encouraging results.
Angharad eLloyd   +2 more
doaj   +1 more source

Trial Watch: Adoptively transferred cells for anticancer immunotherapy [PDF]

open access: yesOncoImmunology, 2017
Immunotherapies aimed at strengthening immune effector responses against malignant cells are growing at exponential rates. Alongside, the impressive benefits obtained by patients with advanced melanoma who received adoptively transferred tumor-infiltrating lymphocytes (TILs) have encouraged the scientific community to pursue adoptive cell transfer (ACT)
Carole Fournier   +8 more
openaire   +5 more sources

Enhanced neointima formation following arterial injury in immune deficient Rag-1-/- mice is attenuated by adoptive transfer of CD8 T cells. [PDF]

open access: yesPLoS ONE, 2011
T cells modulate neointima formation after arterial injury but the specific T cell population that is activated in response to arterial injury remains unknown.
Paul C Dimayuga   +7 more
doaj   +1 more source

VSSP-activated macrophages mediate senescence and tumor inhibition in a preclinical model of advanced prostate cancer

open access: yesCell Communication and Signaling, 2023
Androgen deprivation therapy (ADT) is a standard therapy for prostate cancer (PCa). Though disseminated disease is initially sensitive to ADT, an important fraction of the patients progresses to castration-resistant prostate cancer (CRPC).
Rydell Alvarez-Arzola   +10 more
doaj   +1 more source

Adoptive Transfer of Lung Antigen Presenting Cells

open access: yesBIO-PROTOCOL, 2017
Our protocol describes adoptive transfer of antigen presenting cells (APCs) isolated from the lungs by enzymatic digestion and magnetic enrichment. This protocol can be used to study APC functions and trafficking.
Xiaofeng Zhou, Bethany B. Moore
openaire   +5 more sources

Excessive Costimulation Leads to Dysfunction of Adoptively Transferred T Cells [PDF]

open access: yesCancer Immunology Research, 2020
AbstractAlthough clinical responses with CD19-targeting chimeric antigen receptor (CAR) T-cell treatment have been observed in patients with certain hematologic malignancies, high rates of disease relapse highlight the necessity to understand and improve mechanisms of CAR T-cell failure. Because T-cell dysfunction is thought to contribute to CAR T-cell
Christina Bebernitz   +7 more
openaire   +3 more sources

The cytoskeletal control of B cell receptor and integrin signaling in normal B cells and chronic lymphocytic leukemia

open access: yesFEBS Letters, EarlyView.
In lymphoid organs, antigen recognition and B cell receptor signaling rely on integrins and the cytoskeleton. Integrins act as mechanoreceptors, couple B cell receptor activation to cytoskeletal remodeling, and support immune synapse formation as well as antigen extraction.
Abhishek Pethe, Tanja Nicole Hartmann
wiley   +1 more source

Development of allogeneic NK cell adoptive transfer therapy in metastatic melanoma patients: in vitro preclinical optimization studies. [PDF]

open access: yesPLoS ONE, 2013
Natural killer (NK) cells have long been considered as potential agents for adoptive cell therapy for solid cancer patients. Until today most studies utilized autologous NK cells and yielded disappointing results.
Michal J Besser   +9 more
doaj   +1 more source

Stem Cell-Derived Viral Antigen-Specific T Cells Suppress HIV Replication and PD-1 Expression on CD4+ T Cells

open access: yesViruses, 2021
The viral antigen (Ag)-specific CD8+ cytotoxic T lymphocytes (CTLs) derived from pluripotent stem cells (PSCs), i.e., PSC-CTLs, have the ability to suppress the human immunodeficiency virus (HIV) infection.
Mohammad Haque   +8 more
doaj   +1 more source

Home - About - Disclaimer - Privacy